Consolidated Condensed Statements of Cash Flows (USD $) In Thousands, unless otherwise specified	9 Months Ended
	Sep. 30, 2014	Sep. 30, 2013
Cash flows from operating activities:
Net loss	$ (4,839)	$ (894)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation, depletion and amortization	503	555
Stock-based compensation expense	159	30
Gain on disposal of discontinued operations	(41)
Loss contingency on discontinued operations	3,100
Gain on sale of assets	(47)
Amortization of note receivable - related party transaction fee	(112)	(236)
Other		(16)
Change in operating assets and liabilities:
Accounts receivable and accounts receivable - related party	28	(255)
Prepaid assets and other	(89)	(210)
Trade payables and other	(704)	309
Net cash used in operating activities - continuing operations	(2,042)	(717)
Net cash provided by (used in) operating activities - discontinued operations	67	(163)
Net cash used in operating activities	(1,975)	(880)
Cash flows from investing activities:
Capital expenditures	(6,781)	(3,730)
Purchase of Global shares	(422)	(32)
Net proceeds from sales of assets	271	55
Origination fee from note receivable - related party restructuring		340
Repayment of note receivable - related party	4,500	3,500
Change in restricted cash	(50)
Net cash provided by (used in) investing activities	(2,482)	133
Cash flows from financing activities:
Principal payments on capital lease obligations	(122)
Purchase of treasury stock	(847)	(2,966)
Net cash used in financing activities	(969)	(2,966)
Net decrease in cash and cash equivalents	(5,426)	(3,713)
Cash and cash equivalents at beginning of period	14,302	19,286
Cash and cash equivalents at end of period	8,876	15,573
Supplemental cash disclosures:
Cash paid for interest	89
Noncash financing activities:
Equipment acquired through capital lease obligations	$ 844